May 2020 Calathea Pharma joined to the multidisciplinary international team managing long term multinational Pharmaceutical technology transfer project (non-disclosive).
May 2019 Dr. Alex Weisman and Mr. Yoav Grinberg nominated for mentors of Israeli Export Institute.
June 2019 Dr. Alex Weisman nominated for External expert of Israeli Innovation Authority
July 2019 Calathea Pharma started collaboration with Ramot organisation (Tel Aviv University) for number of research projects;
18. 11. 2018 Calathea Pharma reporting completion of funding for Israeli start up company.
Calathea Pharma Ltd. proud to announce: our assistance to Israeli company developing new technique for bone reconstitution and mineralization, brought positive results. First round of funding successfully completed.
30.08.2018 Calathea Pharma announced collaboration with Israeli company in oncology area.
Calathea Pharma Ltd. happy to announce agreement for collaboration with Israeli bio-medical company (non disclosed), developing new chemical entity and formulation in oncology area.
Calathea Pharma will provide full range of scientific and technical support to ensure successful initiation of Phase I study.
For the list of our services, please, visit our home page.
22.08.2018 Calathea Pharma and Recipharm Israel announced agreement for collaboration
About Recipharm: Established in Sweden in 1995, Recipharm has since grown to become a leading Contract Development and Manufacturing Organization (CDMO). Headquartered in Stockholm, we employ nearly 5 000 people.
Our company unites over 20 facilities across 10 different countries, offering a range of services across two different operating areas, Development and Manufacture.
Recipharm Israel, a part of the development & technology division, offers clients, small or large, a comprehensive range of services, supporting the customer from the initial product concept to the approved pharmaceutical drug, in some cases, through various forms of risk sharing.
Our integrated knowledge exchange between Recipharm’s manufacturing and development units, ensure efficiency and quality during development and pharmaceutical drug transitions from the development phase through to manufacturing phase. https://www.recipharm.com/israel/ness-ziona
Calathea Pharma supports product development and all stages of product lifecycle for customers in the Pharma, Chemical and related industries.
Calathea Pharma holds a key to make the development process controllable and successful for all its stages/parts: IP generation and protection; synthetic process and analytical controls, physico-chemical parameters of the drug substance and drug product, R&D and manufacturing budget and cost control.
Our record of 30 years for generation the success in Pharma industry compliments Recipharm expertise by adding additional management capabilities and market knowledge.